Allena Pharmaceuticals, Inc.
ALNAQ

$122
Marketcap
$0.00
Share price
Country
$0.00
Change (1 day)
$0.02
Year High
$0.00
Year Low
Categories

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts. On September 2, 2022, Allena Pharmaceuticals, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

marketcap

Allena Pharmaceuticals, Inc. (ALNAQ) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2021 -29,461,000 15.89 M 34.76 M 33.01 M
2020 -24,898,000 16.36 M 38.93 M 37.25 M
2019 -19,529,000 16.91 M 34.11 M 33.04 M
2018 -51,663,000 15.77 M 65.23 M 64.47 M
2017 -85,108,000 13.38 M 96.25 M 96.03 M